Eaton Vance Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$5.21M Buy
61,432
+551
+0.9% +$46.7K 0.01% 773
2022
Q2
$5.05M Sell
60,881
-19,925
-25% -$1.65M 0.01% 806
2022
Q1
$6.23M Buy
80,806
+62,834
+350% +$4.84M 0.01% 825
2021
Q4
$1.59M Sell
17,972
-3
-0% -$265 ﹤0.01% 1076
2021
Q3
$1.34M Sell
17,975
-126
-0.7% -$9.4K ﹤0.01% 1015
2021
Q2
$1.51M Buy
18,101
+86
+0.5% +$7.17K ﹤0.01% 1072
2021
Q1
$1.36M Sell
18,015
-3
-0% -$226 ﹤0.01% 1064
2020
Q4
$1.58M Buy
18,018
+566
+3% +$49.6K ﹤0.01% 978
2020
Q3
$1.33M Sell
17,452
-75,552
-81% -$5.75M ﹤0.01% 930
2020
Q2
$11.5M Sell
93,004
-10,108
-10% -$1.25M 0.02% 424
2020
Q1
$8.71M Buy
103,112
+135
+0.1% +$11.4K 0.02% 437
2019
Q4
$8.71M Sell
102,977
-2,497
-2% -$211K 0.02% 485
2019
Q3
$7.11M Sell
105,474
-87
-0.1% -$5.86K 0.02% 520
2019
Q2
$9.04M Sell
105,561
-20,483
-16% -$1.75M 0.02% 449
2019
Q1
$11.2M Sell
126,044
-25,582
-17% -$2.27M 0.03% 391
2018
Q4
$12.9M Sell
151,626
-942
-0.6% -$80.2K 0.03% 318
2018
Q3
$14.8M Sell
152,568
-19,820
-11% -$1.92M 0.03% 334
2018
Q2
$16.2M Sell
172,388
-204,690
-54% -$19.3M 0.04% 306
2018
Q1
$30.6M Sell
377,078
-34,157
-8% -$2.77M 0.04% 314
2017
Q4
$36.7M Sell
411,235
-70,817
-15% -$6.31M 0.09% 203
2017
Q3
$44.9M Buy
482,052
+1,893
+0.4% +$176K 0.12% 164
2017
Q2
$43.6M Sell
480,159
-75,631
-14% -$6.87M 0.11% 175
2017
Q1
$48.8M Sell
555,790
-12,009
-2% -$1.05M 0.13% 163
2016
Q4
$47M Buy
567,799
+244,181
+75% +$20.2M 0.13% 165
2016
Q3
$29.9M Sell
323,618
-91,256
-22% -$8.44M 0.09% 184
2016
Q2
$32.3M Buy
414,874
+364,780
+728% +$28.4M 0.09% 179
2016
Q1
$4.13M Buy
50,094
+452
+0.9% +$37.3K 0.01% 433
2015
Q4
$5.2M Sell
49,642
-769
-2% -$80.6K 0.02% 397
2015
Q3
$5.31M Buy
50,411
+36,411
+260% +$3.83M 0.02% 393
2015
Q2
$1.92M Hold
14,000
0.01% 538
2015
Q1
$1.75M Buy
+14,000
New +$1.75M 0.01% 584